In-stent restenosis: The gold standard has changed

EuroIntervention

Volumn 7, Issue SUPPL. K, 2011, Pages

  Chin, Kenneth ^a  

^a Pantai Hospital   (Malaysia)

Author keywords

Drug eluting balloon; In stent restenosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; PACLITAXEL; RAPAMYCIN;

BALLOON; BARE METAL STENT; BRACHYTHERAPY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELUTING BALLOON; DRUG ELUTING STENT; DRUG RETENTION; DRUG UPTAKE; GOLD STANDARD; HUMAN; IN-STENT RESTENOSIS; PRIMARY PREVENTION; PROSTHESIS FAILURE; REVIEW; STENT THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CATHETERS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HUMANS; METALS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME;

EID: 80355149320     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7SKA7     Document Type: Review

References (19)

1. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-1878. (Pubitemid 29511140)
2. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schomig A. ISARDIABETES Study Investigators. Paclitaxel-eluting or sirolimuseluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670. (Pubitemid 41175674)
3. Saia F, Lemos PA, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW. Routine sirolimus eluting stent implantation for unselected in-stent restenosis; Insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (Research) registry. Heart 2004;90:1183-1188. (Pubitemid 39279907)
4. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMario S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease a randomized controlled trial. JAMA 2005;294:1215-1223. (Pubitemid 41352109)
5. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuhlen H, Schmitt C, Dirschinger J, Schomig A; ISARDESIRE Study Investigators. Sirolimus-eluting stent or paclitaxeleluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-17.
6. Radke PW, Kaiser A, Frost C, Sigwart U. Outcome after treatment of coronary in-stent restenosis: results from a systematic review using meta- analysis techniques. Eur Heart J 2003;24:266-273. (Pubitemid 36207082)
7. Stone GW, Ellis SG, O' Shaughnessy CD, Martin SC, Satler L, McGarry T, Turco MA, Keriakes DJ, Kellley L, Popma JJ, Russell ME. TAXUS V ISR Investigators. Paclitaxel-eluting stents versus vascular brachytherapy for in-stent restenosis within bare-metal stents. The TAXUS V ISR randomized trial. JAMA 2006;295:1253-1263.
8. Holmes DR Jr, Tierstein P, Satlet L, Sketch M, O' Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Carmanica E, Cohen SA, SISR Investigators. Sirolimus-eluting stents versus brachytherapy for in-stent restenosis within bare-metal stents. The SISR randomizes trial. JAMA 2006;295:1264-1273.
9. Mehilli J, Bryne R, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schomig A, Kastari A. Randomised trial of paclitaxel versus sirlolimus eluting stents for treatment of coronary restenosis in sirolimus eluting stents. The ISAR-DESIRE 2 (Intracornary stenting and angiographic results: Drug eluting stents for in-stent restenosis 2) Study. J Am Coll Cardiol 2010; 55:2710-2716.
10. Lee CW, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ. Long term clinical outcomes after sirlolimus eluting stent implantation for treatment of restenosis within bare metal versus drug eluting stents. Cathet and Cardiovasc Interven, 2008;71:594-598. (Pubitemid 351550393)
11. Mishkel G, Moore AL, Markwell S, Shelton MC, Shelton ME. Long term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 2007;49:181-184. (Pubitemid 46054395)
12. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Axel DI, Schroder S, Heinle H, Karsch KR. Local paclitaxel delivery for the prevention of resetnosis: biological effects and efficacy in vivo. J Am Coll cardiol. 2000;35:1969-1976. (Pubitemid 30342882)
13. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810-814. (Pubitemid 39096008)
14. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113-2124. (Pubitemid 44749319)
15. Scheller B, Hehrlein C, Bocksch W, Rutsch W, haghi D, Dietz U, Bohm M, Speck U. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res cardiol. 2008;97:773-781.
16. Unverdorben M, Vallbracht C, Cremers B, Heuer H, hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. paclitaxel-coated balloon catheter versus paclitaxelcoated stent for the treatment of coronary in-stent restenosis. Circulation. 2009;119:2986-2994.
17. ESC guidelines for percutaneous coronary interventions. August 2010. http://www.escardio.org/guidelined-surveys/escguidelines/ Pages/percutaneous- coronary-interventions.aspx.
18. Habara S, Mitsudo K, Kadota K, Goto T, Yamamoto H, Kato H, Oka N, Fuku Y, Hosogi S, Tanaka H, ShigemotoY, Hasegawa D, Saito N, Tsujimoto Y. Paclitaxel-eluting balloon catheter versus repeat drug-eluting stent for the treatment of sirolimus-eluting stent restenosis. Oral presentation. EuroPCR 2010, Paris.
19. Mathey DG, Bruch L, Hengstenberg C, Kleber FX, Kurowski V, Missler J, Moebius WS, Radke R, Rittger H, Scheller B, Schneider H, Zeus T, Zeymer U. German concensus group recommendations for drug-eluting balloon clinical use. Oral presentation. TCT 2010, Washington DC.